Xspray Pharma AB (0GHZ) AI Stock Analysis

Top Page

Xspray Pharma AB

(LSE:0GHZ)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

HyNap formulation platformHyNap gives Xspray a focused platform for developing differentiated or bioequivalent versions of established medicines. Potential improvements in bioavailability and reduced food effects could support licensing, partnering, and commercialization opportunities across specialty pharmaceutical markets.

Negative Factors

No commercial revenueThe absence of reported revenue means Xspray has not yet demonstrated a recurring commercial income stream from its products or technology. This leaves future financial performance dependent on successful development, regulatory progress, partnerships, and eventual market adoption.

Xspray Pharma AB (0GHZ) vs. iShares MSCI United Kingdom ETF (EWC)

Market Cap: SEK 559.52M
Dividend Yield: ―
Average Volume (3M): 2,448
Price to Earnings (P/E): -3.1
Beta (1Y): 0.01
Revenue Growth: ―
EPS Growth: 44.46%
Country: UK
Employees: 24
Sector: Healthcare
Sector Strength: 51
Industry: Biotechnology

Xspray Pharma AB Business Overview & Revenue Model

Company Description

Xspray Pharma AB (publ), a pharmaceutical firm based in Solna, Sweden, specializes in developing protein kinase inhibitors for precise cancer treatments. Their current drug pipeline includes HyNap-Nilo, aimed at chronic myeloid leukemia; HyNap-Sora,...

Xspray Pharma AB Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

GB:0GHZ against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SE:CAMX	80Outperform	SEK 40.76B	59.09	15.54%	―	<0.01%	-6.75%
SE:XBRANE	53Neutral	SEK 291.57M	-5.90	-13.41%	―	-38.80%	-120.18%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
SE:SPAGO	43Neutral	SEK 32.09M	-0.85	-106.23%	―	-97.37%	25.28%
SE:VICO	39Underperform	SEK 2.73B	-5.05	-53.71%	―	-48.40%	-1.06%

* Healthcare Sector Average

Performance Comparison

GB:0GHZ and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
GB:0GHZ	Xspray Pharma AB	10.16	-16.09	-61.30%
SE:CAMX	Camurus AB	673.00	46.00	7.34%
SE:VICO	Vicore Pharma Holding AB	9.70	-1.18	-10.85%
SE:XBRANE	Xbrane Biopharma AB	14.15	3.35	31.02%
SE:SPAGO	Spago Nanomedical AB	0.04	-0.11	-72.79%
SE:BIOWKS	Bio-Works Technologies AB	3.00	0.26	9.49%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Xspray Pharma AB AI Stock Analysis